Dr Dan Hardy is the founder of Microsol, a company dedicated to developing novel inhaled and nasal drug delivery technologies through innovative aerosol technology by combining advanced characterization techniques with computational modelling.
Dr. Dan Hardy holds a PhD in physical chemistry from the University of Bristol and has a background spanning industry and academic research and education. Subsequent to completing his PhD, he held a teaching role at the EPSRC CDT in Aerosol Science.
His research has focussed on fundamental aerosol processes for better understanding in particle engineering, disease transmission and inhalation. This includes developing novel instrumentation and models to describe aerosol microphysics and understand aerosol processes with a bottom-up approach.
Dan is also a visiting fellow for Zinc VC, helping develop mission-led companies tackling today’s most pressing challenges. He has previously been awarded the Aerosol Society Doctoral Student and Doctoral Thesis awards.
